Latest News about BMRN
Recent news which mentions BMRN
BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says
July 05, 2023
From Benzinga
From Benzinga
BioMarin's Roctavian US Launch: Focus on Commercial Strategy Amid EU Failures, Analyst Points Out
June 30, 2023
Tickers
BMRN
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks to Buy With Explosive Upside Potential
June 22, 2023
From InvestorPlace
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
3 Biotech Stocks With Blockbuster Potential
May 24, 2023
From InvestorPlace
A volatile summer is coming as Fed pause, debt tussle meet. Shelter in these stocks, says strategist
May 01, 2023
From MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
April 20, 2023
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
From InvestorPlace
From Motley Fool
From Benzinga
After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use
March 08, 2023
From Benzinga
Why BioMarin Shares Are Plunging Today?
March 06, 2023
From Benzinga
BioMarin Hints Probable Delay For US Approval For Roctavian, But Analyst Convinced For Transformative 2023
February 28, 2023
Tickers
BMRN
From Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
